• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human BCL2L15 Polyclonal Antibody

The antibody against BCL2L15 was raised in rabbit using the Fusion protein of Human BCL2L15 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.

ADC-32412A

The antibody against BCL2L15 was raised in rabbit using the Fusion protein of Human BCL2L15 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-32412A ClonalityPolyclonal
Host SpeciesRabbitTarget NameBCL2L15
FormLiquidSpecies ReactivityHuman
IsotypeIgGStorage Buffer0.05% NaN3, 40% Glycerol., pH7.4 PBS
Purification MethodAntigen affinity purifiedConjugateNon-conjugated
ApplicationELISA, IHC, WBStorageUpon receipt

Immunogen Information


Immunogen DescriptionFusion protein of Human BCL2L15Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ5TBC7
Background Information
  • Uniprot Id

    Q5TBC7

  • Target Species

    Human

  • Target Name

    BCL2L15

  • Target Full Name

    Bcl-2-like protein 15

  • Target Research Area

    others

  • Target Synonyms

    AC124698.1; B2L15_HUMAN; Bcl-2-like protein 15; Bcl2-L-15; BCL2-like 15; Bcl2l15; Bfk; C1orf178; FLJ22588; Gm566; Pro apoptotic Bcl 2 protein

  • Target Background

    Predicted to be involved in apoptotic process and regulation of apoptotic process. Predicted to be active in cytosol and nucleus.

Inquire Rabbit anti-Human BCL2L15 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification